Cameroon Malaria Vaccine Program

In January 2024, Cameroon launched the world’s first malaria vaccine program for children, marking a significant milestone in public health. The program utilizes the RTS,S vaccine, developed by GSK, to target the deadliest strain of malaria, P. falciparum. This vaccine, which requires four doses starting from around 5 months of age, will be offered free of charge and integrated with other routine child immunizations. While the vaccine’s effectiveness is moderate, it represents a critical step towards reducing the malaria burden in Africa, where the disease has a profound impact. Challenges such as logistical distribution and ensuring complete immunization remain, but the program’s launch is seen as a major achievement in the fight against malaria.